Ufmylation: An Emerging Ubiquitin-Like Modification in ER Stress and Disease

Overview

UFMylation is a post-translational modification (PTM) that covalently attaches ubiquitin-like proteins to specific amino acid residues of target proteins. The process contributes to protein degradation, signal transduction, cell cycle regulation, DNA repair, and transcriptional regulation. The name derives from "ubiquitination" and "ubiquitin-like modification." It represents a relatively new class of PTM that resembles ubiquitination but uses distinct ubiquitin-like proteins. The discovery of UFMylation has expanded understanding of the diversity and complexity of the ubiquitin system. Among the ubiquitin-like modifications, UFMylation stands out because it is tightly coupled to the endoplasmic reticulum and to the ribosome.

Core Molecules and Enzymatic System of UFMylation

UFM1 is the central protein of this pathway. It is a ubiquitin-like protein with roughly 30% sequence homology to ubiquitin, although its three-dimensional structure more closely resembles SUMO. UFM1 forms an isopeptide bond with the lysine (Lys) residue of target proteins through its C-terminal glycine.

The modification proceeds through a defined enzymatic cascade. UBA5 (ubiquitin-like modifier activating enzyme 5) is the E1 activating enzyme. UFC1 (UFM1-conjugating enzyme 1) is the E2 conjugating enzyme and transfers activated UFM1 to the E3 ligase. UFL1 (UFM1-specific ligase 1) is the E3 ligase and mediates specific binding of UFM1 to target proteins. UFSP2 (UFM1-specific protease 2) is the deUFMylation enzyme that removes UFM1 modifications.

The basic process unfolds in three steps. During activation, UFM1 is first activated by UBA5 to form a UFM1-AMP complex. During conjugation, activated UFM1 binds UFC1 to form a UFM1-acylated complex. During transfer, UFM1 is transferred to target proteins to form UFMylated proteins, a step that typically requires UFL1.

Schematic diagram of the human UFMylation pathway

Pathway Context and Cellular Outcomes

The UFMylation pathway regulates different physiological processes depending on stimuli and cellular context.

In the endoplasmic reticulum (ER) stress response, the UFM1 pathway is often associated with ER stress, and its expression is controlled by the major transcription factor XBP1. Gene deletions in this pathway are implicated in ER-dependent apoptosis across various settings, while its expression helps counteract drug-induced ER stress.

In plasma B-cell differentiation, the pathway is activated by LPS, which increases transcription of UFBP1 (a UFM1 pathway interaction factor) through XBP1 expression. UFBP1 inhibits activation of the sensors IRE1 and PERK. This promotes ER expansion and immunoglobulin production as a feedback response.

In breast cancer cell lines, exposure to estradiol (E2) promotes interaction and subsequent polymerization of the nuclear receptor ERalpha with ASC1. ASC1 UFMylation forms a scaffold that recruits p300 and SRC, activating cell proliferation. ASC1 is also a key regulator of hematopoietic stem cell differentiation, and its deletion in mouse models is associated with pancytopenia.

Interaction between the UFM1 pathway, ER stress, and cell fate

Biological Functions of UFMylation

Protein quality control in the ER. UFMylation primarily participates in ER-associated degradation (ERAD). When unfolded proteins accumulate in the ER during ER stress, UFMylation is activated. It targets ribosomal proteins such as RPL26 and ER membrane proteins, promoting degradation of misfolded proteins. It also forms a complex with UFBP1 (UFM1-binding protein 1) to regulate ER homeostasis.

Ribosome biogenesis and translation regulation. UFMylation modifies ribosomal proteins such as RPL26, influencing ribosome assembly and translation efficiency. Knockout of UFM1 in mice results in embryonic lethality, highlighting its critical role in development.

DNA damage repair and cell cycle regulation. UFMylation participates in the DNA damage response. For example, it modifies C53 (also known as CDK5RAP3) to regulate the ATM/ATR signaling pathway. It is also associated with cell cycle checkpoints, including G2/M phase arrest.

Other functions. UFMylation may additionally contribute to mitochondrial function, autophagy, and immune regulation, although these mechanisms remain to be fully elucidated. Each of these areas is an active line of investigation that links the pathway to broader cellular stress responses.

UFMylation and Disease

Cancer. Dysregulation of UFMylation is associated with various cancers. In breast cancer, UFL1 deletion leads to genomic instability and tumorigenesis. In leukemia, UBA5 mutations are linked to myelodysplastic syndromes (MDS). The pathway may influence tumor progression by regulating ER stress and DNA repair.

Neurological disorders. UFM1 deletion in mouse models causes cerebellar developmental abnormalities and motor dysfunction. The modification is also associated with protein homeostasis imbalances in neurodegenerative diseases such as Parkinson's and Alzheimer's.

Hematological disorders. UFSP2 mutations cause recessive hereditary blood disorders, including congenital dyserythropoietic anemia. UFMylation-related genes show altered expression across different cancers, making the pathway an active area for mechanistic and biomarker research.

UFMylation-related genes across different cancers

Tools for UFMylation Research

ANT BIO PTE. LTD. provides specific antibodies and agarose beads for UFMylation studies. The polyclonal antibody option is the K-ε-GV Rabbit Polyclonal Antibody (Catalog No. S0B1323). The monoclonal antibody option is the S-RMabMixTM K-ε-GV Rabbit mAb (Catalog No. S0B1323 series). An ELISA binding assay confirms that the K-ε-GV antibody specifically binds the K-ε-GV peptide rather than related sequences. That specificity is important because UFM1-derived residues resemble other ubiquitin-like modifications and cross-reactivity would confound enrichment results. Together these reagents support detection, enrichment, and functional analysis across the UFMylation pathway and its related ubiquitin-like modifications.

ELISA binding assay for K-epsilon-GV antibody specificity

Conclusion

UFMylation has moved from a curiosity in the ubiquitin field to a recognized regulator of ER stress, ribosome biology, DNA repair, and hematopoiesis. Its link to cancer, neurological disease, and blood disorders makes it a compelling target for both basic and translational research. ANT BIO PTE. LTD. supplies validated antibodies and agarose beads to support these studies.

Product Information

All products are supplied for research use only and are not intended for diagnostic or therapeutic procedures in humans or animals.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

ANT BIO PTE. LTD. supplies high-quality reagents and solutions for life science research. Our sub-brands cover the full research workflow: Starter for antibodies and immunological assay kits, UA-Bio for recombinant proteins and drug discovery solutions, and Absin for general reagents and other detection kits. Explore our product portfolio at www.antbioinc.com.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.